ATE310525T1 - Verwendung von sulfatiden zur behandlung von diabetes - Google Patents

Verwendung von sulfatiden zur behandlung von diabetes

Info

Publication number
ATE310525T1
ATE310525T1 AT01902928T AT01902928T ATE310525T1 AT E310525 T1 ATE310525 T1 AT E310525T1 AT 01902928 T AT01902928 T AT 01902928T AT 01902928 T AT01902928 T AT 01902928T AT E310525 T1 ATE310525 T1 AT E310525T1
Authority
AT
Austria
Prior art keywords
isoform
sulfatide
carbon atoms
sulfatides
treat diabetes
Prior art date
Application number
AT01902928T
Other languages
English (en)
Inventor
Karsten Buschard
Pam Fredman
Original Assignee
Karsten Buschard
Pam Fredman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karsten Buschard, Pam Fredman filed Critical Karsten Buschard
Application granted granted Critical
Publication of ATE310525T1 publication Critical patent/ATE310525T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01902928T 2000-01-27 2001-01-29 Verwendung von sulfatiden zur behandlung von diabetes ATE310525T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0000258A SE0000258D0 (sv) 2000-01-27 2000-01-27 Pharmaceutical preparation and method for treatment of diabetes
PCT/SE2001/000169 WO2001054700A1 (en) 2000-01-27 2001-01-29 Pharmaceutical preparation and method for treatment of diabetes

Publications (1)

Publication Number Publication Date
ATE310525T1 true ATE310525T1 (de) 2005-12-15

Family

ID=20278246

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01902928T ATE310525T1 (de) 2000-01-27 2001-01-29 Verwendung von sulfatiden zur behandlung von diabetes

Country Status (18)

Country Link
US (1) US6908904B2 (de)
EP (1) EP1320372B1 (de)
JP (1) JP2003520818A (de)
KR (1) KR20030005168A (de)
CN (1) CN1396831A (de)
AT (1) ATE310525T1 (de)
AU (1) AU778994B2 (de)
BR (1) BR0107871A (de)
CA (1) CA2398206A1 (de)
CZ (1) CZ20022519A3 (de)
DE (1) DE60115263D1 (de)
HU (1) HUP0203676A3 (de)
MX (1) MXPA02007196A (de)
PL (1) PL356778A1 (de)
RU (1) RU2266123C2 (de)
SE (1) SE0000258D0 (de)
SK (1) SK10762002A3 (de)
WO (1) WO2001054700A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0000258D0 (sv) 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes
US20110118197A1 (en) * 2005-09-29 2011-05-19 Vipin Kumar Chaturvedi Prevention of hepatic ischemic reperfusion injury by administration of sulfatides
US9821035B2 (en) 2012-08-22 2017-11-21 Regimmune Corporation Preparation for preventing or treating type I diabetes
WO2019238841A1 (en) * 2018-06-15 2019-12-19 Københavns Universitet Coating medical devices to avoid fibroblast overgrowth

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK84691D0 (da) * 1991-05-07 1991-05-07 Karsten Buschard Visse glycolipider og specifikke catchere for disse til anvendelse ved profylaxe eller terapi af diabetes, og/eller dermed forbundne komplikationer samt anvendelse af saadanne glycolipider til detektion af oe-celle-antistoffer (ica) i et individ og anvendelse af saadanne catchere til detektion af langerhans-oe-celler i pancreas-praeparater
US5302609A (en) * 1992-12-16 1994-04-12 The Regents Of The University Of Michigan Treatment of diabetic nephropathy
SE9601817D0 (sv) * 1996-05-13 1996-05-13 Karsten Buschard Novel glycolipid complexex and their uses
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
EP0988860B1 (de) * 1997-04-10 2005-01-12 Kirin Beer Kabushiki Kaisha Verwendung von a-Glycosylceramiden zur Herstellung eines therapeutischen Mittelszur Behandlung von Autoimmunkrankheiten
JP2001527046A (ja) * 1997-12-30 2001-12-25 エイプラス サイエンス インベスト アーベー ガラクトシルセラミド、グルコシルセラミド、ラクトシルセラミド、並びに前糖尿病、糖尿病および／または関連合併症の予防もしくは治療に使用するためのその特定キャッチャー
SE0000258D0 (sv) 2000-01-27 2000-01-27 A & Science Invest Ab Pharmaceutical preparation and method for treatment of diabetes

Also Published As

Publication number Publication date
HUP0203676A2 (hu) 2003-04-28
DE60115263D1 (de) 2005-12-29
EP1320372B1 (de) 2005-11-23
US6908904B2 (en) 2005-06-21
SK10762002A3 (sk) 2003-07-01
CN1396831A (zh) 2003-02-12
MXPA02007196A (es) 2003-01-28
AU778994B2 (en) 2004-12-23
EP1320372A1 (de) 2003-06-25
HUP0203676A3 (en) 2003-08-28
WO2001054700A1 (en) 2001-08-02
RU2002122982A (ru) 2004-03-20
AU3069101A (en) 2001-08-07
CZ20022519A3 (cs) 2003-06-18
SE0000258D0 (sv) 2000-01-27
CA2398206A1 (en) 2001-08-02
BR0107871A (pt) 2002-11-05
RU2266123C2 (ru) 2005-12-20
PL356778A1 (en) 2004-07-12
US20030004115A1 (en) 2003-01-02
KR20030005168A (ko) 2003-01-17
JP2003520818A (ja) 2003-07-08

Similar Documents

Publication Publication Date Title
ATE481970T1 (de) Zusammensetzungen enthaltend capsaicin oder capsaicin analoge und ein anästhetikum
ATE207352T1 (de) Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE69814917D1 (de) Transdermale therapeutische vorrichtung mit capsaicin und seinen analogen
ATE234090T1 (de) Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
ATE206305T1 (de) Verfahren zur behandlung von gemüts- oder geisteskrankheiten und von gemüts- oder geisteskrankheiten, die von anfällen begleitet sind
SE9804064D0 (sv) Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells
DE69426471D1 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
BR9809678A (pt) Derivados de triptolìdeo úteis no tratamento de doenças autoimunes
ATE203511T1 (de) Selektive beta3-adrenergische agonisten
ATE230609T1 (de) Verfahren zur behandlung von entzündungen und zusammensetzungen dafür
KR950031063A (ko) 프라바스타틴을 이용하여 관상 동맥 아테롬성 동맥경화증의 진행 속도를 감소시키는 방법
ATE310525T1 (de) Verwendung von sulfatiden zur behandlung von diabetes
WO1997022354A3 (de) Anwendung eines medikaments und verwendung eines stoffgemischs zur herstellung eines medikaments
ATE126061T1 (de) Verwendung von lithium zur behandlung oder prophylaxe von molluscum contagiusum.
DE69630055D1 (de) Verwendung von olanzapin oder eines salzes für die herstellung eines medikaments für die behandlung von autismus und mentaler retardation
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
HK1042238A1 (en) Treatment of symptoms of parkinson's disease with an agent comprising a dopaminergic substance and a local anaesthetic of the anilide group
RU2014020C1 (ru) Способ лечения стилоидита
UA29106A (uk) Спосіб лікування вібраційної хвороби
RO117893B1 (ro) Metodă de anestezie generală, la cabaline

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties